Skip 
Navigation Link

1215 South Walnut Ave.
Demopolis, AL 36732 map map 

Access to Care: 334.289.2410

Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
CBD Is the Rage, But More Science Needed on Safety, EffectivenessMany Parents Would Switch Doctors Over Vaccination Policy, Poll FindsPot Poisonings Among Kids, Teens Double After Medical Marijuana Law PassedNearly Half of U.S. Patients Keep Vital Secrets From Their DoctorsFDA Proposes Graphic Warning Labels on CigarettesMany Doctors Refusing Care of People Prescribed OpioidsAll U.S. Adults Should Be Screened for Illicit Drug Use, National Panel UrgesAmericans' Trust in Scientists Follows a Sharp Political DivideRaising Legal Smoking Age to 21 WorksPure CBD Won't Make You Fail a Drug Test, But…Health Tip: Donate Blood SafelyRoutine Screening for Pancreatic Cancer Not Warranted, Expert Panel SaysResearchers 'Spin' Clinical Trial Findings in Top Psych Journals: StudyMore 'Buyer Beware' Warnings for Unregulated Stem Cell ClinicsSome of Most Common, Deadly Cancers Get the Least Research MoneyTraveling Abroad? Make Sure Your Measles Shot Is Up to DateBlood Donations Needed: Red CrossKeep Unused Meds Out of the Hands of AddictsFew U.S. Universities Are Smoke-FreeNeed Emergency Air Lift to Hospital? It Could Cost You $40,000California Took on Anti-Vaxxers, and WonAnti-Vaccine Movement a 'Man-Made' Health Crisis, Scientists WarnAHA News: Even the Threat of Homelessness May Bring Higher Stroke RiskFDA Warns Two Kratom Marketers About False ClaimsExperts Want Doctors to Add Vaping to Youth Prevention PitchMany Health Care Workers With Flu, Colds Still Go to Work: StudyGlobal Efforts to Cut Smoking Show Mixed ResultsOne Simple Food Substitution Might Help Save the PlanetAHA News: 3 Simple Steps Could Save 94 Million Lives WorldwideRace Affects Life Expectancy in Major U.S. CitiesDrugstores Often Don't Have Opioid Antidote in Stock, Philly Study ShowsAntibiotics Pollute Rivers Worldwide: StudyAHA News: For LGBTQ Patients, Discrimination Can Become Barrier to Medical CareImmigrants Make Up 1 in 4 U.S. Health Care WorkersFDA Takes Hard Look at CBDPatients Who Read Doctors' Notes More Likely to Take Their MedsU.S. Measles Cases for 2019 Already Exceed All Annual Totals Since 1992: CDCBreathe Easier, New York City: Clean-Air Taxi Rules Are WorkingDoctor Burnout Costly for Patients, Health Care SystemBlood Banks Could Help Screen for Hereditary High CholesterolRed Cross Needs Type O Blood to Ease ShortageLess Pain, More Car Crashes: Legalized Marijuana a Mixed BagPolitical Controversies Could Fuel Bullying of LGBT Youth: StudyCBD -- It's Everywhere, But Does It Work?Brief EMS Training Saves Lives After Brain InjuryU.S. Improves Emergency Readiness, but Gaps PersistSlowing Climate Change Could Cut Health Costs, Save MoneyDispensing Opioid Antidote Without a Prescription Might Save LivesNot Just Opioids: Deaths Tied to Cocaine, Meth Are Soaring, TooMost Americans Hit Hard by Medical Bills
Questions and AnswersVideosLinksBook Reviews
Related Topics

Health Insurance
Healthcare

White House Plan to Disclose Drug Prices May Not Drive Down Costs: Study

HealthDay News
by -- Robert Preidt
Updated: Jan 25th 2019

new article illustration

FRIDAY, Jan. 25, 2019 (HealthDay News) -- By itself, a Trump administration plan to make drug companies disclose the cost of their medicines in TV ads is unlikely to help tame drug prices, a new study shows.

Researchers did find that revealing the cost of expensive drugs in ads would significantly lower patient demand for those drugs, but that impact largely vanished when the ads included a modifier, such as an explanation that the drug would be low-cost or free with insurance coverage or other discounts.

"Will price disclosure work at all? The answer is yes: price disclosure works, absent anything else," said study co-author Bill Tayler, a professor of accounting at Brigham Young University in Salt Lake City.

"But in a world where pharmaceutical companies behave logically, they will surely use a modifier of sorts that would unwind the entire benefit of this legislation," Tayler added in a university news release.

The study included 580 participants who were told to imagine they had recently been diagnosed with type 2 diabetes and were then shown one of five ads for a fictional diabetes prescription drug.

One version of the ad did not disclose the drug's price, while the other four mentioned either a low ($50 a month) or a high ($15,500 a month) price. Two ads were modified to say that eligible patients may be able to get the drug for free because of insurance coverage or coupon availability.

Participants who saw the ad with the high-price and no modifier were much less likely to say they'd ask their doctor about the drug, ask their insurance provider about the drug, research the drug online, or take the drug.

But those who saw the ads with high prices and modifying language were still interested in the drug, the findings showed.

According to study co-author Ge Bai, an associate professor of accounting at Johns Hopkins University, "Price disclosure in drug ads works only under the 'tell the price, only the price, nothing but the price' scenario."

The proposal to include prices in drug ads is opposed by the pharmaceutical industry.

Tayler concluded that "the suggested policy is unlikely to do harm, but it is also unlikely to help much to control pharmaceutical prices. This is not the most effective route and it could be very costly in terms of the lawsuits that are going to result. Why fight the legal battle if it's not going to work?"

The study was published Jan. 22 in JAMA Internal Medicine.

More information

The American Hospital Association has more on rising drug prices.